Thornburg Investment Management Inc
Source: SEC Form 13F · as of Mar 2026Thornburg Investment Management Inc holds 14 biotech & pharma companies tracked by BioSniper, totaling $1.25B in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$1.25B
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 2,858,651 | $555.7M |
| MRKMerck & Co., Inc. | 3,728,673 | $448.5M |
| ABBVAbbVie Inc. | 502,832 | $109.4M |
| PFEPFIZER INC | 2,242,186 | $63.0M |
| LLYELI LILLY & Co | 60,178 | $55.3M |
| INSMINSMED Inc | 38,337 | $6.3M |
| CYTKCYTOKINETICS INC | 83,190 | $5.5M |
| RGENREPLIGEN CORP | 29,401 | $3.5M |
| BMYBRISTOL MYERS SQUIBB CO | 38,400 | $2.3M |
| RPRXRoyalty Pharma plc | 31,409 | $1.5M |
| ZTSZoetis Inc. | 5,816 | $688K |
| ICLRICON plc | 6,010 | $665K |
| NVSNovartis AG | 4,114 | $628K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 10,608 | $599K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.